Erin Burkhart, SVP of Gilead Sciences GILD, has filed 0 purchases and 5 sales on the open market. The latest trade was on 09/22.

EB

EB

Erin Burkhart

SVP, Controllership

Company

Gilead Sciences GILD

First filing

23/03/17

Trades

22 trades

Buys / sales

0 / 5

12-month net buying

No record

Last trade

09/22

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Biomarin PharmaceuticalBMRN	Open-market sale10b5-1 plan	25/05/20	25/05/20	1,786 sh	$59.31	$105,927.66	−11.2%
Biomarin PharmaceuticalBMRN	Open-market sale10b5-1 plan	25/03/19	25/03/20	1,295 sh	$71.52	$92,618.4	−7.1%
Biomarin PharmaceuticalBMRN	Open-market sale10b5-1 plan	25/02/24	25/02/25	1,344 sh	$68.38	$91,902.72	−9.3%
Biomarin PharmaceuticalBMRN	Open-market sale10b5-1 plan	24/08/13	24/08/15	714 sh	$90.00	$64,260	−4.7%
Biomarin PharmaceuticalBMRN	Open-market sale10b5-1 plan	24/04/10	24/04/12	2,286 sh	$90.00	$205,740	−12.4%